Previous studies aimed at understanding the molecular mechanisms of DBA and the 5q‐ syndrome have shown that decreased expression of specific RPGs (RPS6, RPS14, and RPS19) leads to p53 activation (Narla & Ebert, 2010; Raiser et al, 2014). The gene discussed is TP53; the disease is Diamond-Blackfan anemia.